Get startedLog in
    Picture of Alligator Bioscience AB logo

    ATORX — Alligator Bioscience AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Alligator Bioscience: Primary Endpoint Of Optimize-1 Trial Was Met

    Picture of Alligator Bioscience AB logoAlligator Bioscience AB
    20/06/2024 08:16
    June 20 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * PRIMARY ENDPOINT OF OPTIMIZE-1 TRIAL WAS MET, WITH
OBJECTIVE
RESPONSE RATE (ORR) OF 40.4% IN 57 EVALUABLE PATIENTS

Source text for Eikon:  ID:nMFN7L7qMV 
Further company coverage:  ATORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Alligator Bioscience AB

    See all news